Rxsight Operating Margin from 2010 to 2024
| RXST Stock | USD 50.38 0.81 1.63% |
Check Rxsight financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rxsight's main balance sheet or income statement drivers, such as Tax Provision of 18.9 K, Net Interest Income of 3.4 M or Interest Income of 6.9 M, as well as many indicators such as Price To Sales Ratio of 14.82, Dividend Yield of 0.0 or PTB Ratio of 9.1. Rxsight financial statements analysis is a perfect complement when working with Rxsight Valuation or Volatility modules.
Rxsight | Operating Margin |
Latest Rxsight's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Rxsight over the last few years. It is Rxsight's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rxsight's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.24) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Rxsight Operating Margin Regression Statistics
| Arithmetic Mean | (14.18) | |
| Coefficient Of Variation | (65.86) | |
| Mean Deviation | 8.50 | |
| Median | (20.56) | |
| Standard Deviation | 9.34 | |
| Sample Variance | 87.27 | |
| Range | 19.9955 | |
| R-Value | 0.83 | |
| Mean Square Error | 29.78 | |
| R-Squared | 0.68 | |
| Significance | 0.0001 | |
| Slope | 1.73 | |
| Total Sum of Squares | 1,222 |
Rxsight Operating Margin History
About Rxsight Financial Statements
Rxsight shareholders use historical fundamental indicators, such as Operating Margin, to determine how well the company is positioned to perform in the future. Although Rxsight investors may analyze each financial statement separately, they are all interrelated. The changes in Rxsight's assets and liabilities, for example, are also reflected in the revenues and expenses on on Rxsight's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses used in cataract surgery in the United States and internationally. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. Rxsight operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 221 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.